Northwire Canada EditionTuesday, July 14, 2026
Northwire
W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%

Healthcare

Page 58
  1. Feb 20, 2026 · 07:25 · KNE

    Kane Biotech Announces Publication of revyve(TM) Wound Gel Article in the International Wound Journal

    Kane Biotech Announces Publication of revyve(TM) Wound Gel Article in the International Wound Journal

    01
  2. Feb 20, 2026 · 07:03 · FRX

    Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK(TM) in Treating Adults with Head & Neck Cancers

    Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK(TM) in Treating Adults with Head & Neck Cancers

    02
  3. Feb 20, 2026 · 07:01 · TLT

    Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

    Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

    03
  4. Feb 20, 2026 · 07:00 · VHI

    VitalHub Announces Q4 2025 Conference Call Date

    VitalHub Announces Q4 2025 Conference Call Date

    04
  5. Feb 19, 2026 · 17:27 · KNE

    Kane Biotech adds U.S. distributors for revyve products

    Kane Biotech adds U.S. distributors for revyve products

    05
  6. Feb 19, 2026 · 16:40 · WELL

    Well Health, Healwell roll out Welltrust

    Well Health, Healwell roll out Welltrust

    06
  7. Feb 19, 2026 · 12:46 · EPRX

    Eupraxia prices $55-million (U.S.) public offering

    Eupraxia prices $55-million (U.S.) public offering

    07
  8. Feb 19, 2026 · 09:00 · GSD

    Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

    Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

    08
  9. Feb 19, 2026 · 08:31 · CYTO

    Cytophage Announces Operational Restructuring

    Cytophage Announces Operational Restructuring

    09
  10. Feb 19, 2026 · 07:25 · KNE

    Kane Biotech Expands Commercial Activities in the United States

    Kane Biotech Expands Commercial Activities in the United States

    10
  11. Feb 19, 2026 · 07:00 · COV

    Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

    Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

    11
  12. Feb 19, 2026 · 07:00 · WELL

    WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

    WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

    12
  13. Feb 19, 2026 · 04:35 · 4543

    Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships

    Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships

    13
  14. Feb 19, 2026 · 03:59 · MBIO

    Mindbio arranges $650,000 private placement

    Mindbio arranges $650,000 private placement

    14
← Newer Older →